Literature DB >> 21669938

Micronucleus frequencies in peripheral blood lymphocytes of children with chronic kidney disease.

Gonca Cakmak Demircigil1, Banu Aykanat, Kibriya Fidan, Kaan Gulleroglu, Umut Selda Bayrakci, Aylin Sepici, Bahar Buyukkaragoz, Hamdi Karakayali, Mehmet Haberal, Esra Baskin, Necla Buyan, Sema Burgaz.   

Abstract

One of the crucial adverse effects of chronic kidney disease (CKD) and its treatment is an elevated cancer risk. There are no data on cytogenetic effects in children with CKD or children undergoing dialysis or those who have received a transplant. In this study, cytogenetic effects in children with CKD in pre-dialysis (PreD) stage, on regular haemodialysis (HD) and transplanted (Tx) compared with a control group of healthy children has been investigated using the cytokinesis-blocked micronucleus (CBMN) assay and fluorescence in situ hybridisation (FISH) combined with CBMN (CBMN-FISH) in peripheral blood lymphocytes. The results revealed a significant increase (P < 0.001) in micronucleus (MN) frequencies [mean ± SD (n)] in the PreD, HD and Tx groups versus the control group [CBMN assay; 9.19 ± 2.61 (16), 9.07 ± 4.86 (15), 6.12 ± 5.33 (17) versus 1.60 ± 0.99 (20), respectively]. Moreover, centromere negative micronucleus (C- MN) and centromere positive micronucleus (C+ MN) frequencies were significantly higher in each subgroup children (PreD, HD and Tx) than in the control group (P < 0.01) although children in Tx group had lower C- MN frequencies than PreD and lower C+ MN frequencies than PreD and HD groups (P < 0.05). Additionally, MN frequencies in mononuclear cells, nucleoplasmic bridges and nuclear buds in binucleated cells were increased in children with CKD (P < 0.001, P < 0.001, P > 0.05, respectively). The nuclear division index significantly decreased in Tx group relative to the control, PreD and HD groups (P < 0.001). Associations between cytogenetic parameters and creatinine or blood urea nitrogen were found (P < 0.05). To provide longer and better life expectancy of children with CKD and treatment modes, further research is needed to better understand and avoid these effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669938     DOI: 10.1093/mutage/ger027

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  2 in total

Review 1.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

Review 2.  DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers.

Authors:  Nicole Schupp; Helga Stopper; August Heidland
Journal:  Oxid Med Cell Longev       Date:  2016-05-25       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.